18F-DCFPyL

18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer

Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy

18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy

Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer

Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor

Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL

18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer

Multimodal Machine Learning Characterization of Solid Tumors

Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer

Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT

PSMA PET Registry (18F-DCFPyL)

Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan

Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy

Hepatocellular Carcinoma Imaging Using PSMA PET/CT

PET/MRI for the Staging of Newly Diagnosed Prostate Cancer

18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate Cancer

18F-DCFPyL Positron Emission Tomography (PET) in Intermediate or High Risk Prostate Cancer

18F-DCFPyL PET/CT in High-grade Epithelial Ovarian Cancer (PET HOC)

Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer